Rankings
▼
Calendar
MNOV FY 2023 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena
MNOV
MediciNova, Inc.
$69M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$1M
100.0% margin
Operating Income
-$10M
-990.0% margin
Net Income
-$9M
-857.2% margin
EPS (Diluted)
$-0.17
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$710,710
Balance Sheet
Total Assets
$66M
Total Liabilities
$4M
Stockholders' Equity
$62M
Cash & Equivalents
$51M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$0
—
Gross Profit
$1M
$0
—
Operating Income
-$10M
-$15M
+32.3%
Net Income
-$9M
-$14M
+39.1%
← Q4 2022
All Quarters
Q1 2023 →